(Q44360397)

English

Frequency of adverse clinical events in the 12 months following successful intracoronary stent placement in patients treated with aspirin and ticlopidine (without warfarin).

scientific article published in March 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Frequency of adverse clinical events in the 12 months following successful intracoronary stent placement in patients treated with aspirin and ticlopidine (without warfarin). (English)

1 reference

Europe PubMed Central

2 December 2017

1 reference

based on heuristic

inferred from title

author name string

Berger PB

1

1 reference

Europe PubMed Central

2 December 2017

Bell MR

2

1 reference

Europe PubMed Central

2 December 2017

Grill DE

3

1 reference

Europe PubMed Central

2 December 2017

Melby S

4

1 reference

Europe PubMed Central

2 December 2017

Holmes DR Jr

5

1 reference

Europe PubMed Central

2 December 2017

language of work or name

0 references

publication date

1 March 1998

1 reference

Europe PubMed Central

2 December 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

2 December 2017

81

1 reference

Europe PubMed Central

2 December 2017

6

1 reference

Europe PubMed Central

2 December 2017

713-718

1 reference

Europe PubMed Central

2 December 2017

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2901005-9

7 January 2021

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2901005-9

7 January 2021

In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2901005-9

7 January 2021

Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2901005-9

7 January 2021

Benefit of intracoronary ultrasound in the deployment of Palmaz-Schatz stents

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2901005-9

7 January 2021

Intracoronary ultrasound observations during stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2901005-9

7 January 2021

Utilization of the coronary balloon-expandable coil stent without anticoagulation or intravascular ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2901005-9

7 January 2021

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2901005-9

7 January 2021

A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2901005-9

7 January 2021

Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2901005-9

7 January 2021

Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2901005-9

7 January 2021

Intracoronary stent implantation in native coronary arteries and saphenous vein grafts: a consecutive experience with six types of stents without prolonged anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2901005-9

7 January 2021

Intracoronary-stent placement for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2901005-9

7 January 2021

Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angio

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2901005-9

7 January 2021

A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2901005-9

7 January 2021

Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regime

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2901005-9

7 January 2021

Identifiers

10.1016/S0002-9149(97)01005-9

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44360397&oldid=1371362140"